Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22023,195,1.61 [1.22-2.14],0.0007960317681989
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23244,251,1.64 [1.29-2.09],5.667448098846698e-05
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22968,1772,1.40 [1.27-1.55],7.996226914229472e-12
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23252,552,1.33 [1.12-1.59],0.0013982803173085
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22489,4262,1.30 [1.22-1.39],2.106811912682399e-15
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22430,4336,1.35 [1.26-1.43],9.860477660022192e-20
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22957,1436,1.30 [1.16-1.45],3.6481334259820113e-06
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23155,131,1.57 [1.12-2.21],0.0095931737358989
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20415,1313,1.45 [1.29-1.62],1.3697255869788862e-10
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19693,1597,1.60 [1.44-1.76],4.227417066579617e-20
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,19189,343,1.63 [1.31-2.02],8.923934486877519e-06
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15129,2768,1.35 [1.24-1.46],7.213017200273567e-13
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19129,501,1.32 [1.09-1.60],0.0053381731402101
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23228,1707,1.30 [1.18-1.44],3.256692205356037e-07
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,23348,648,1.29 [1.09-1.52],0.002415653306105
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22451,1255,1.37 [1.22-1.54],1.202979814748908e-07
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23276,1448,1.42 [1.27-1.58],1.769519987037739e-10
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21772,251,1.66 [1.30-2.11],3.581845103365391e-05
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23408,67,1.15 [0.67-1.97],0.6063538229537264
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23094,1266,1.37 [1.22-1.54],1.031213487674425e-07
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23104,80,1.15 [0.71-1.87],0.5598232041459223
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23341,141,1.43 [1.02-2.01],0.0389396914895095
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23319,119,1.21 [0.82-1.79],0.3366539750097621
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21703,507,1.78 [1.51-2.10],5.496834458280452e-12
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21507,311,1.21 [0.94-1.54],0.1395462175699712
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21660,139,1.08 [0.74-1.58],0.6904922481755267
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23393,52,2.42 [1.56-3.75],7.970819212842587e-05
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23340,174,0.82 [0.57-1.18],0.2890936851886904
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral warts,23221,55,0.96 [0.52-1.78],0.8984447826920341
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23245,79,0.94 [0.56-1.58],0.8170983504921383
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,23112,265,1.11 [0.85-1.45],0.4502593329438047
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23324,38,1.79 [0.99-3.23],0.0527588833424721
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23307,44,1.14 [0.59-2.19],0.6982023489134674
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,11157,86,1.03 [0.64-1.66],0.9125148594298316
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22936,1685,1.08 [0.97-1.20],0.1803432408962371
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of meninges,23392,64,1.06 [0.61-1.86],0.825346802974785
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23312,80,1.66 [1.08-2.53],0.0195035967391112
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23380,119,1.10 [0.74-1.65],0.6349941148847527
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of ovary,12181,80,1.37 [0.86-2.19],0.1909828102591649
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23368,444,1.12 [0.91-1.38],0.2772735817686559
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Caecum,23373,384,0.91 [0.72-1.15],0.4355026938753514
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23257,88,1.11 [0.70-1.77],0.6570926713429122
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23365,254,1.37 [1.06-1.76],0.015635323241769
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,23323,413,1.11 [0.90-1.38],0.3373508870265107
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23251,678,1.06 [0.89-1.25],0.5300559001378919
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23351,544,0.99 [0.81-1.20],0.8821735989429469
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Carcinoma in situ of breast,9160,50,0.91 [0.47-1.77],0.7722819146393602
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",9204,68,1.40 [0.85-2.32],0.1887433359258438
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16703,73,1.06 [0.63-1.79],0.831023956091526
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16731,101,0.81 [0.50-1.32],0.4023850830005806
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23350,127,1.02 [0.68-1.52],0.9295624401738148
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma, any site",23351,124,1.04 [0.69-1.55],0.8549658569654808
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Leiomyoma of uterus,11910,170,0.99 [0.70-1.41],0.96774033812706
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Lung cancer and mesothelioma,14817,483,1.10 [0.90-1.35],0.3382755006535351
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Lymphoid leukaemia,16704,74,0.95 [0.55-1.62],0.8416399340712628
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16859,229,1.01 [0.75-1.37],0.9447653272648242
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16954,324,1.17 [0.92-1.50],0.1982726613043869
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9284,105,1.33 [0.88-2.01],0.1726130785651292
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16739,109,2.42 [1.76-3.31],4.191576755516194e-08
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16780,150,0.98 [0.68-1.43],0.9315195731620084
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16754,124,1.32 [0.91-1.93],0.1471002095229383
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9266,87,1.04 [0.64-1.69],0.8752123840400224
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16758,128,1.15 [0.78-1.70],0.4733302003999652
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8443,992,0.98 [0.85-1.13],0.7900427729097137
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16769,139,0.78 [0.52-1.18],0.2446160732687873
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16723,93,1.46 [0.96-2.23],0.0798028369308889
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16776,146,1.29 [0.90-1.84],0.1672054491713523
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi,23260,186,1.21 [0.89-1.65],0.2307385945475119
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi of trunk,23379,78,1.49 [0.96-2.31],0.0749433595738214
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanoma in situ,16683,112,0.93 [0.60-1.45],0.7481478897819058
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16753,123,0.95 [0.63-1.45],0.8166191618959088
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16831,201,1.07 [0.78-1.46],0.6926904718681879
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16960,330,0.91 [0.70-1.17],0.4564574825910172
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16759,129,1.02 [0.69-1.53],0.9079878197955834
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Other benign neoplasms of skin,23232,168,0.76 [0.53-1.10],0.1495278168942492
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",18139,1509,1.01 [0.90-1.14],0.8075962718424361
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18225,1595,1.03 [0.92-1.15],0.6218117041707895
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23100,398,0.98 [0.78-1.23],0.8683843774610176
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21057,167,2.07 [1.58-2.70],1.196395328568582e-07
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22773,71,1.61 [1.03-2.52],0.037176304348425
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22628,3538,1.28 [1.19-1.38],8.546507215486269e-12
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21666,73,1.55 [0.97-2.48],0.0656720988055076
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22928,62,1.54 [0.94-2.52],0.0849713195601809
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22883,1993,1.33 [1.21-1.46],3.293434984835473e-09
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22881,1991,1.33 [1.21-1.46],2.795636022871697e-09
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21006,116,1.44 [0.98-2.11],0.0600086906617498
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23039,1446,1.46 [1.31-1.62],4.344957223299186e-12
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22980,114,1.84 [1.32-2.58],0.0003396696850236
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22775,73,1.33 [0.82-2.14],0.2462258991840961
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22778,76,1.22 [0.74-1.99],0.4337350698484402
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23223,357,1.69 [1.39-2.06],1.8265523903487042e-07
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23278,39,1.04 [0.51-2.15],0.912263068623444
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23161,295,1.80 [1.45-2.22],5.314357156955705e-08
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21732,139,1.20 [0.83-1.74],0.3299992280938234
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15662,419,1.74 [1.45-2.09],2.328266616265611e-09
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21886,105,0.94 [0.60-1.47],0.7901269281128476
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21895,114,1.59 [1.11-2.29],0.0123191080431541
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,15315,72,1.30 [0.79-2.13],0.3026756903689008
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21737,65,0.70 [0.38-1.28],0.2417832703396941
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20945,324,1.19 [0.94-1.52],0.1553412675634545
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22606,970,1.23 [1.07-1.42],0.0032020926875203
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22121,485,1.16 [0.95-1.42],0.1441151288236231
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21855,219,1.01 [0.74-1.37],0.9706749529460792
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23117,1445,0.91 [0.81-1.03],0.1336739795405765
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19690,1400,0.92 [0.81-1.04],0.1799713237869528
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15336,93,1.01 [0.63-1.62],0.9610019071932492
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21085,101,0.60 [0.36-1.00],0.0484627786581729
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15613,370,1.29 [1.04-1.61],0.0209716916553968
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,15298,55,1.78 [1.09-2.89],0.0210969029574257
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19894,4651,0.98 [0.91-1.05],0.510887097915319
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15510,267,1.38 [1.07-1.78],0.0117242273684133
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15958,715,1.37 [1.18-1.60],5.906072006940388e-05
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23346,375,1.15 [0.92-1.44],0.2256616988994842
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23134,163,1.34 [0.97-1.85],0.0761335956598762
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15399,156,1.54 [1.12-2.10],0.0070705373255944
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",15325,82,1.73 [1.15-2.59],0.0078588274584232
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22761,1777,1.02 [0.92-1.14],0.6981467868115087
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15629,386,1.94 [1.62-2.31],3.771188213467399e-13
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15675,432,1.70 [1.42-2.03],7.275514973502415e-09
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",16116,873,1.05 [0.91-1.22],0.5002513949261556
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15421,178,1.19 [0.87-1.65],0.2779519653385468
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23124,153,1.34 [0.95-1.87],0.0915101877167344
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,16148,905,1.12 [0.96-1.30],0.1410325366564967
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15906,663,1.27 [1.08-1.50],0.0044112611410402
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20702,81,1.67 [1.09-2.56],0.0188813448991081
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21744,6501,1.05 [0.99-1.11],0.1163181176259907
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21045,61,0.84 [0.45-1.55],0.5737338445445422
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21033,49,0.79 [0.40-1.60],0.5186912560542952
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23220,1931,0.99 [0.90-1.10],0.9098155273964624
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23218,1929,0.99 [0.90-1.09],0.8747872465236012
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21050,66,1.21 [0.71-2.06],0.4885283239325371
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23046,1148,0.98 [0.86-1.12],0.7800373483177292
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17501,2258,1.34 [1.22-1.46],6.029041184860076e-11
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23392,317,1.82 [1.48-2.23],1.5184508544915057e-08
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21768,132,2.18 [1.63-2.93],1.9848293357207746e-07
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22018,120,1.37 [0.94-2.00],0.1004633562891222
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22065,167,1.01 [0.71-1.43],0.9720639638341628
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15445,202,1.11 [0.81-1.52],0.5253504811803852
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20580,187,1.96 [1.50-2.56],8.552179340706994e-07
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2506,101,1.60 [1.13-2.27],0.008134351425023
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2674,311,1.17 [0.93-1.46],0.1731181258388213
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20478,85,3.65 [2.71-4.92],1.989952091230974e-17
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2478,76,1.90 [1.29-2.81],0.0012106217253948
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22551,2158,1.47 [1.34-1.60],1.2124108530548008e-17
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22274,638,1.24 [1.04-1.47],0.0139266651351609
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21078,457,1.45 [1.20-1.76],0.0001636846414192
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16369,1126,1.31 [1.16-1.48],2.0715353622872044e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23272,305,1.17 [0.92-1.50],0.2013827265302552
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21890,271,0.87 [0.65-1.16],0.334926722217676
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,20217,1587,1.02 [0.91-1.14],0.7657602416451782
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21997,378,1.00 [0.79-1.27],0.9987004373714286
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21708,89,1.88 [1.29-2.76],0.0011103251976647
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21915,296,1.66 [1.33-2.07],9.419270370488245e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11850,2875,1.47 [1.36-1.59],9.997281724178232e-23
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,AV-block,17784,687,1.55 [1.33-1.80],2.2615724522495688e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23322,583,1.20 [1.01-1.44],0.0398963555417573
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cardiac arrest,9240,265,1.81 [1.43-2.29],9.483519873079128e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17303,206,2.23 [1.76-2.83],3.2890609871774176e-11
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",17208,111,2.37 [1.73-3.25],7.27915898436666e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23402,83,1.75 [1.17-2.64],0.0068232510022905
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,18671,1574,1.55 [1.40-1.71],1.9998592609263844e-17
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21391,2786,1.21 [1.12-1.31],4.313383114199522e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18789,9008,1.11 [1.06-1.17],1.360282177276485e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21823,335,1.19 [0.94-1.51],0.1558871348155413
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Endocarditis,17201,104,2.28 [1.64-3.16],7.545065403305463e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23114,1689,1.80 [1.64-1.97],1.8054449835487561e-37
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertension,20034,8010,1.10 [1.04-1.16],0.0002792049564546
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",20054,8030,1.09 [1.04-1.15],0.0004845092328501
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23232,95,4.72 [3.78-5.89],8.399313574687033e-43
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12288,264,2.78 [2.30-3.36],2.76167475733669e-26
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12237,213,1.96 [1.52-2.51],1.3098661483959918e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypotension,23221,1660,1.32 [1.19-1.46],1.2614740206423297e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22097,149,1.37 [0.98-1.94],0.0691564975125479
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21565,2935,1.17 [1.08-1.27],9.156897706602476e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22884,809,1.45 [1.26-1.67],3.630026056904639e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17625,528,1.57 [1.32-1.87],3.525248415251994e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22708,1072,1.15 [1.00-1.31],0.0428453153987216
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19553,923,1.19 [1.03-1.37],0.0181824467547827
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23277,192,1.05 [0.76-1.44],0.7822585079415454
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23364,410,1.11 [0.89-1.37],0.3651424409098138
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Oesophageal varices,21554,66,4.57 [3.39-6.16],2.4470490565651133e-23
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other aneurysm,21726,107,1.29 [0.86-1.95],0.2143463878533164
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,17700,603,1.57 [1.34-1.85],4.864699581859044e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21756,137,1.62 [1.17-2.26],0.0038373608738981
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21952,333,1.50 [1.20-1.86],0.0002836105945394
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,17325,228,1.59 [1.22-2.06],0.000541308860279
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other disorders of veins,21609,121,1.61 [1.13-2.29],0.0088429591753671
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21536,48,2.10 [1.26-3.50],0.004606895039047
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21324,92,1.32 [0.86-2.04],0.209327886584014
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21670,182,1.69 [1.28-2.23],0.0002439936182413
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18578,1481,1.62 [1.46-1.79],1.999621572459869e-20
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21623,62,4.27 [3.21-5.67],2.150753035236835e-23
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22358,739,1.43 [1.23-1.66],2.187859751472068e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22624,534,2.13 [1.84-2.47],7.924432482057023e-24
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22223,991,1.22 [1.06-1.40],0.0045040777119668
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9399,424,1.92 [1.59-2.30],4.171814695122709e-12
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22185,602,1.79 [1.54-2.08],3.701117870658626e-14
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21913,425,1.18 [0.96-1.46],0.1167298680388171
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22702,612,1.19 [1.00-1.41],0.0553866544654404
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23306,980,1.64 [1.45-1.85],3.3385006337062575e-15
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17617,520,1.64 [1.38-1.94],1.4298949985536324e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22617,527,2.14 [1.85-2.49],6.4426502152388264e-24
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21501,269,1.75 [1.40-2.21],1.4346361813228037e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22868,920,1.44 [1.26-1.65],8.712036335893428e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22853,960,1.43 [1.25-1.63],1.0650210177130585e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22064,63,1.23 [0.71-2.12],0.4630940161630521
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21725,106,1.42 [0.95-2.12],0.084674313292977
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22402,327,1.26 [1.00-1.60],0.0539115331290579
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21974,338,0.96 [0.75-1.23],0.7450477851669983
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Varicose veins,22009,521,1.57 [1.32-1.86],2.871420045102801e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21640,125,1.01 [0.67-1.52],0.9710870534170344
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23129,959,1.15 [1.00-1.33],0.0452692096786639
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23324,335,1.49 [1.20-1.85],0.0002770596327435
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19991,1400,1.00 [0.88-1.13],0.976603427423597
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Any mental disorder,22865,4274,1.07 [1.00-1.15],0.053734125108448
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23295,396,1.42 [1.16-1.74],0.0007724878943067
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20064,1473,0.93 [0.82-1.05],0.2205431575861551
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18676,85,1.33 [0.84-2.09],0.2214036836422424
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Smoking dependency,22890,1192,1.15 [1.00-1.31],0.0475193921520497
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20057,1466,1.21 [1.09-1.35],0.0004970883056641
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Vascular dementia,22497,235,1.55 [1.20-2.00],0.0008875001682209
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Alzheimer disease,23404,596,1.15 [0.96-1.37],0.1345005668833527
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",14323,111,1.24 [0.82-1.86],0.3137646519304098
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Bell's palsy,21527,88,1.81 [1.23-2.68],0.0029145207286782
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21940,501,1.09 [0.90-1.33],0.3776367256038055
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Cerebral cysts,22950,251,1.21 [0.92-1.58],0.1765475783300892
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23330,414,1.15 [0.93-1.43],0.1980065479604403
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22543,75,1.02 [0.61-1.71],0.9308009154004112
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23386,68,1.20 [0.72-2.00],0.4825652241141877
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22786,87,1.01 [0.62-1.64],0.9696582455271188
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Epilepsy,21870,309,1.24 [0.97-1.58],0.0794537292990932
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22933,1372,1.14 [1.02-1.28],0.0261995395928884
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23350,937,0.90 [0.78-1.05],0.1961899954271302
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22739,3494,1.17 [1.09-1.26],2.4342400732097985e-05
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23018,54,2.08 [1.30-3.33],0.0022309387852294
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Hemiplegia,23255,339,1.27 [1.01-1.59],0.0435906908050198
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Hydrocephalus,22774,75,1.16 [0.70-1.92],0.5632291698457249
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23391,75,1.39 [0.87-2.23],0.1705260918107311
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21507,68,0.93 [0.53-1.64],0.8034640699050704
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21513,74,0.72 [0.41-1.26],0.248014210255662
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Memory loss,22240,143,1.34 [0.94-1.89],0.1021075959141085
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Migraine,21847,286,0.81 [0.61-1.08],0.1450367270697169
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23356,262,0.73 [0.54-0.99],0.0408921604231407
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Motor neuron disease,14412,176,1.11 [0.79-1.55],0.5606138733682112
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23269,61,0.80 [0.43-1.48],0.4820794936071926
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22686,1247,1.05 [0.92-1.19],0.4787924859711426
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Neurological diseases,21893,4414,1.10 [1.03-1.18],0.005584374652302
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22796,328,0.98 [0.76-1.26],0.8745287544560464
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21871,432,0.96 [0.77-1.20],0.7192483879059859
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23326,357,1.62 [1.32-1.98],3.0945116469061727e-06
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17495,986,1.12 [0.97-1.29],0.1196362639014938
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22787,88,0.87 [0.53-1.42],0.5686294528791727
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22861,162,1.30 [0.94-1.80],0.1125919008245063
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22650,237,1.06 [0.79-1.41],0.7091229874738314
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21538,99,1.83 [1.27-2.65],0.0012109446065498
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other headache syndromes,21614,53,0.85 [0.45-1.62],0.6204997454086226
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,23288,589,1.07 [0.89-1.29],0.4559779740002143
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,22084,523,1.11 [0.92-1.34],0.2713633105797801
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Parkinson's disease,23371,696,0.86 [0.72-1.02],0.0914848685370391
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22744,45,0.86 [0.43-1.74],0.6773720317290766
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23405,109,0.80 [0.51-1.27],0.3419365358675342
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,23170,445,1.14 [0.93-1.38],0.2075455096187927
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23031,62,1.31 [0.77-2.23],0.3198392517759859
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23393,205,1.08 [0.79-1.47],0.6327041926438073
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21510,71,0.90 [0.52-1.57],0.7155318966253752
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23404,602,1.15 [0.96-1.37],0.1355463282521845
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22434,229,1.52 [1.17-1.97],0.0019176417109679
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22746,157,1.21 [0.86-1.70],0.2839031857162034
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22940,572,0.87 [0.71-1.06],0.1760525280393779
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23146,269,1.48 [1.17-1.89],0.0012769215514205
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22153,69,1.37 [0.84-2.24],0.2043952670201016
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22123,39,1.55 [0.84-2.87],0.1644985542929608
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23280,73,0.73 [0.41-1.29],0.2833184797168557
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23085,229,0.92 [0.68-1.26],0.6122862089590648
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2482,77,1.90 [1.30-2.79],0.0010282112424542
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3060,115,1.74 [1.28-2.37],0.0004157054539517
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22700,111,0.79 [0.50-1.24],0.3082272961101033
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23101,1444,1.21 [1.08-1.35],0.0012277551584994
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22981,897,1.09 [0.94-1.26],0.2724851292879383
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22393,309,0.82 [0.63-1.08],0.1555748358193231
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23329,961,0.89 [0.77-1.04],0.1387612275105472
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23398,83,0.67 [0.39-1.15],0.1457500173027259
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23255,887,0.84 [0.72-0.99],0.033372776528941
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23362,506,0.92 [0.75-1.14],0.4455876139316155
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23283,229,1.14 [0.85-1.52],0.3869771456357891
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22187,103,1.08 [0.70-1.66],0.737110360206622
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22187,103,0.76 [0.47-1.22],0.2534575748353936
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22162,78,0.77 [0.45-1.33],0.3513236019204443
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23270,1030,1.12 [0.97-1.28],0.1138609705165982
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22509,269,0.93 [0.70-1.23],0.6195094324784667
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22441,73,0.72 [0.41-1.28],0.2593480286876812
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22980,124,1.07 [0.71-1.60],0.7502959924009821
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23252,396,0.92 [0.72-1.16],0.4617390285725735
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22590,222,0.78 [0.57-1.08],0.1371739319035085
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23199,145,1.14 [0.79-1.64],0.4830704478790156
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22929,689,1.14 [0.97-1.35],0.1173472724687034
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22751,162,1.15 [0.82-1.61],0.4292252911962806
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20916,3284,1.06 [0.98-1.15],0.1567174015377172
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23207,351,0.91 [0.71-1.17],0.4454733097067369
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23390,190,1.15 [0.84-1.57],0.3886410997947291
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22634,550,1.11 [0.92-1.34],0.2556496778146382
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22946,90,0.85 [0.52-1.40],0.5218705822347711
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23389,74,0.78 [0.45-1.37],0.3898168939332374
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22214,130,1.23 [0.85-1.79],0.2744626968659544
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22263,179,0.94 [0.67-1.33],0.7434549930600094
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21821,164,1.19 [0.85-1.67],0.3036007565467661
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22432,64,1.11 [0.64-1.92],0.7222755020257812
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21732,75,1.22 [0.75-2.01],0.4233077184498253
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22357,117,1.35 [0.91-1.99],0.133346397744809
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22539,299,1.10 [0.85-1.42],0.462962413132742
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22246,162,1.61 [1.19-2.17],0.0019655266461046
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21752,95,0.65 [0.39-1.08],0.096465911308872
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21791,134,1.55 [1.10-2.17],0.0115284733448748
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20404,2772,1.11 [1.02-1.21],0.0164166717669405
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22179,95,0.87 [0.54-1.41],0.5844762000877639
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23104,515,1.10 [0.90-1.33],0.3506082583819171
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22669,80,1.27 [0.79-2.04],0.3243055673539018
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22801,212,1.12 [0.83-1.52],0.4564430207067369
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23180,111,1.23 [0.82-1.85],0.3263877333625101
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23358,141,1.19 [0.83-1.71],0.3553774698213335
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23266,120,1.22 [0.83-1.80],0.315941335817802
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23133,64,0.84 [0.46-1.52],0.563902347241326
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23139,70,1.18 [0.71-1.98],0.5200659623030099
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23298,1263,1.02 [0.90-1.16],0.7545221135487039
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22991,956,1.04 [0.90-1.21],0.5726333149113783
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22191,156,0.58 [0.39-0.87],0.0089920168894985
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22126,91,1.45 [0.95-2.20],0.0827848741742007
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23210,67,1.60 [1.01-2.55],0.0475737573254711
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23332,189,1.39 [1.04-1.86],0.027711931180136
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23207,64,1.44 [0.87-2.37],0.1556383515183944
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,All influenza,20695,159,1.68 [1.24-2.27],0.00078688147793
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20692,156,1.69 [1.24-2.29],0.0007729024515342
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14437,103,1.15 [0.74-1.79],0.5304968047038151
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23295,240,1.02 [0.76-1.37],0.8937895535476224
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15672,1735,1.15 [1.03-1.28],0.0131697440611274
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16046,1712,1.12 [1.01-1.25],0.0343148768098763
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22883,180,1.51 [1.12-2.04],0.0067811751851334
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20641,105,1.53 [1.04-2.27],0.0316892782953435
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Bronchiectasis,19619,517,1.33 [1.11-1.60],0.0024466116625076
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19175,73,1.07 [0.63-1.81],0.800766131686714
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22262,3160,1.16 [1.07-1.25],0.0002938850262985
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22171,73,0.76 [0.43-1.34],0.3460002334637101
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22236,138,0.76 [0.51-1.15],0.1977273182838638
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23110,1647,1.32 [1.19-1.47],1.165753082133603e-07
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22179,81,0.69 [0.40-1.19],0.1795874557955913
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21236,6176,1.19 [1.13-1.26],8.191271024731695e-10
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22436,338,0.95 [0.74-1.22],0.7060954723376542
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Early onset COPD,21573,110,1.80 [1.26-2.55],0.0010781527595449
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Emphysema,19543,441,1.29 [1.06-1.59],0.0131313132367119
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22087,459,1.15 [0.94-1.41],0.1799938491938569
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23145,2609,1.34 [1.24-1.46],1.0256070263440306e-12
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22130,502,1.23 [1.01-1.48],0.0361342773416943
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Later onset COPD,22876,1537,1.29 [1.16-1.44],3.18046096530629e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23388,501,1.00 [0.82-1.22],0.9954913176088596
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Nasal polyp,22198,100,0.78 [0.49-1.26],0.3104320599275513
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23119,1313,1.32 [1.18-1.48],1.697843835767028e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23110,2708,1.40 [1.30-1.52],2.9834641047190214e-17
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22857,759,0.91 [0.77-1.08],0.2806335039323158
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other pleural conditions,20468,66,1.94 [1.26-2.98],0.0025973825788634
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23284,599,1.35 [1.14-1.60],0.0004687629218956
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23274,1726,1.36 [1.23-1.50],1.0692383078675921e-09
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pleural effusion,21784,1382,1.60 [1.44-1.78],1.1642048589290453e-18
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pleural plaque,20656,254,1.36 [1.05-1.77],0.0203753260883915
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22854,2318,1.38 [1.27-1.50],1.1844212441800525e-13
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23277,390,1.03 [0.82-1.29],0.8291382717894342
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pneumothorax,20573,171,1.49 [1.10-2.03],0.0102126424315297
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pollen allergy,23393,204,0.99 [0.72-1.36],0.9401932690618882
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pulmonary oedema,22778,93,1.81 [1.23-2.65],0.0024633696887279
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14405,71,1.63 [1.01-2.62],0.0468757629409709
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23096,1290,1.33 [1.19-1.50],9.380878759225852e-07
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22340,242,1.02 [0.76-1.36],0.8942594289807605
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Viral pneumonia,20841,305,1.18 [0.92-1.51],0.1986205291142197
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22891,244,1.12 [0.84-1.48],0.4414473348271018
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7465,120,1.57 [1.07-2.31],0.0208928534585544
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14825,62,0.94 [0.52-1.68],0.8276327327757972
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,23288,131,0.73 [0.48-1.12],0.1481951804985757
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute gastritis,16253,104,1.06 [0.68-1.65],0.8072964448497648
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21335,198,0.91 [0.66-1.27],0.5849371620542608
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute peritonitis,22906,112,2.06 [1.50-2.83],8.976940469497828e-06
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22410,64,4.27 [3.16-5.78],5.273836411755221e-21
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Barrett oesophagus,16664,515,1.15 [0.95-1.40],0.145487768012117
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21282,145,1.04 [0.72-1.51],0.8369840985089134
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22981,145,1.03 [0.71-1.50],0.858788911346199
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholecystitis,21361,224,0.82 [0.59-1.12],0.2141080894935261
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,22202,1065,1.05 [0.92-1.21],0.4576624406607176
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,16502,353,1.16 [0.92-1.47],0.2178429874029471
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21193,56,1.03 [0.57-1.88],0.9149980382224624
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23264,127,4.68 [3.84-5.71],2.4090885132287003e-52
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Coeliac disease,21641,129,0.74 [0.48-1.14],0.1722958781095842
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Collagenous colitis,21639,104,1.67 [1.15-2.42],0.0074432656415283
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23287,158,1.05 [0.74-1.50],0.7792065821575884
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Constipation,23116,2157,1.09 [0.99-1.20],0.0761021469199582
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn disease,21624,89,1.41 [0.92-2.17],0.1134522254740058
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23051,68,1.30 [0.78-2.15],0.3129371409460909
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21616,81,1.36 [0.86-2.16],0.1823029813158743
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Dental caries,22777,190,1.24 [0.91-1.68],0.1663503037264201
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20212,2584,0.92 [0.84-1.01],0.0848588062718083
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,23319,162,0.67 [0.45-0.98],0.0404842924955914
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of liver,23281,935,2.06 [1.83-2.30],4.724458673759714e-35
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20806,4657,1.04 [0.97-1.11],0.2632974550703653
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23065,478,1.09 [0.89-1.33],0.4151927389667756
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23314,520,1.17 [0.96-1.41],0.1126100642955999
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22682,95,1.23 [0.79-1.90],0.3597614481515465
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22552,60,0.75 [0.41-1.41],0.374727609347759
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23064,1552,1.27 [1.14-1.41],1.1817263627617671e-05
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of tongue,22570,98,1.13 [0.73-1.77],0.5837341198257976
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22673,1536,1.07 [0.95-1.19],0.2695895702268823
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18580,3817,1.01 [0.94-1.08],0.8303996938187602
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,16401,252,1.48 [1.15-1.91],0.002433700946596
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23308,204,1.33 [1.00-1.78],0.0476794117607801
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23366,27,1.93 [0.98-3.82],0.0578558856566514
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22495,149,4.32 [3.56-5.24],1.1336976788147094e-49
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14871,108,1.35 [0.91-2.01],0.1307350760362228
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,16721,572,0.93 [0.76-1.13],0.4679079364419301
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,16579,430,1.36 [1.11-1.67],0.0029339382597549
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18856,2707,0.93 [0.85-1.02],0.1075040889724704
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16807,658,1.33 [1.13-1.57],0.0006657557581827
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16891,8314,1.01 [0.96-1.07],0.6209231856569579
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,GI-bleeding,22801,1289,1.31 [1.17-1.47],5.16293386749508e-06
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22633,46,0.92 [0.47-1.80],0.7985812336939969
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15767,1198,1.06 [0.94-1.21],0.3426877456733769
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22416,70,4.04 [3.02-5.40],6.05056186908565e-21
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Hernia,21314,3686,0.92 [0.85-0.99],0.0285307056810288
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Impacted teeth,23370,25,1.99 [0.99-4.01],0.0545131080013595
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Impaction of intestines,14842,79,0.98 [0.58-1.65],0.9346061796613072
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,18743,1115,0.93 [0.81-1.06],0.2690160354889026
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17754,126,1.02 [0.69-1.52],0.9041223244909672
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14882,119,1.30 [0.88-1.91],0.1860739611343144
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21660,148,0.85 [0.58-1.26],0.4236321805998186
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,15282,519,1.18 [0.97-1.43],0.0907925908785726
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23373,343,1.89 [1.56-2.29],7.835530917561476e-11
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22327,792,1.17 [1.00-1.36],0.0509305389926641
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22639,1104,1.21 [1.06-1.38],0.0037980067166652
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16371,222,1.28 [0.96-1.71],0.0883224875347168
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophagitis,16859,710,1.12 [0.95-1.33],0.1761192866785745
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23349,136,1.34 [0.94-1.91],0.1050839566967859
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17716,88,1.01 [0.63-1.63],0.961560968980098
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,16158,1395,1.06 [0.94-1.20],0.3075744918763139
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21500,363,0.98 [0.77-1.25],0.8995348070371854
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21287,150,0.88 [0.60-1.28],0.4979343933129969
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,16720,1957,1.20 [1.09-1.33],0.0001537199769461
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21052,6289,1.04 [0.99-1.10],0.1376284212633747
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22530,209,1.07 [0.79-1.45],0.676445808714956
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,23119,773,2.09 [1.85-2.37],3.854486880700842e-31
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16928,779,1.16 [1.00-1.36],0.0570865828776584
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21352,215,1.33 [1.00-1.77],0.0499547831652349
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23236,442,1.01 [0.82-1.26],0.8945974408362601
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17258,1109,1.29 [1.14-1.47],8.174231092829811e-05
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22818,1306,1.31 [1.17-1.47],4.803103988076586e-06
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22768,181,0.95 [0.68-1.34],0.7892248886818618
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16966,2203,1.09 [0.99-1.20],0.0636512224791026
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18341,2192,1.11 [1.01-1.23],0.0254231560874154
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22460,114,3.50 [2.74-4.47],9.686478282950857e-24
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22507,972,1.23 [1.07-1.41],0.0035194897010087
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",15216,453,1.10 [0.89-1.35],0.385295368584905
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23362,31,1.69 [0.86-3.32],0.1272727627850763
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,15390,627,1.13 [0.95-1.35],0.1599570000401667
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21672,160,1.37 [0.99-1.89],0.0557924593152795
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23393,54,1.21 [0.68-2.16],0.524783093976718
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22580,104,0.89 [0.56-1.41],0.6260340187315022
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Toxic colitis,21617,82,1.06 [0.65-1.74],0.8108189576955971
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16493,344,0.99 [0.77-1.26],0.9082319274339063
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21706,171,1.18 [0.85-1.64],0.3199431759453229
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21671,136,1.27 [0.89-1.82],0.1933476163600868
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,17886,258,1.16 [0.89-1.51],0.2674362067055966
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,15012,249,1.37 [1.05-1.78],0.0186621291962241
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ventral hernia,17920,292,0.97 [0.75-1.27],0.8496162660060516
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Volvulus,14857,94,1.16 [0.74-1.82],0.526425807039364
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23296,431,1.14 [0.92-1.40],0.2363893747382127
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23036,67,1.14 [0.68-1.93],0.6165688882818977
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20811,170,1.24 [0.89-1.73],0.2023884197276857
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22764,839,1.61 [1.41-1.83],1.9929363179372986e-12
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22071,146,1.23 [0.86-1.74],0.2567627988895288
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21282,641,1.60 [1.37-1.87],2.1864448729482038e-09
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23055,319,1.20 [0.94-1.52],0.1450991434399466
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23302,566,1.11 [0.92-1.33],0.273732795224414
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22785,49,1.35 [0.76-2.41],0.305648049285379
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21781,3777,1.25 [1.16-1.34],5.27692239910296e-10
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22967,445,0.98 [0.79-1.22],0.8691216082218951
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22831,309,0.97 [0.75-1.26],0.840073886170204
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23016,1091,1.50 [1.33-1.69],3.187186309178681e-11
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23384,61,1.01 [0.56-1.80],0.982096104071959
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20698,57,0.47 [0.24-0.92],0.0288260937673618
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22586,64,1.12 [0.65-1.92],0.6896002640848526
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23041,305,1.20 [0.94-1.54],0.13958644553105
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21252,611,1.09 [0.91-1.30],0.3593944342729963
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20731,90,1.26 [0.80-1.97],0.3208808875866563
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23316,97,1.49 [1.00-2.24],0.0517097344029681
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22164,239,1.67 [1.30-2.13],5.0469600831209005e-05
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23197,228,1.10 [0.83-1.47],0.5066463743822983
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22833,97,0.97 [0.61-1.56],0.9045374593773056
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20722,81,1.30 [0.81-2.09],0.2738918741916051
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22779,2138,1.33 [1.22-1.46],3.647824457773025e-10
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21298,657,1.15 [0.97-1.37],0.1033943735124374
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20735,94,1.25 [0.80-1.94],0.3205892177483682
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23311,342,0.99 [0.78-1.27],0.9636843952701224
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22811,75,0.95 [0.56-1.61],0.8455869180794612
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23249,280,1.00 [0.76-1.30],0.9728043818999884
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23329,464,1.12 [0.92-1.38],0.2579317509523191
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20768,127,1.01 [0.67-1.52],0.9541080726305432
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20984,343,1.22 [0.97-1.55],0.0904464532217415
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23317,452,1.13 [0.92-1.39],0.2477592556739326
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20983,342,2.34 [1.95-2.80],2.1641845998037566e-20
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23377,158,1.48 [1.08-2.03],0.0160480167402198
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19503,82,0.74 [0.43-1.26],0.2646814657158403
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20620,6520,1.09 [1.03-1.15],0.0036527833267672
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19196,5096,1.05 [0.98-1.12],0.1586840364386773
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19475,54,0.40 [0.20-0.81],0.0108288216572509
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19414,149,1.07 [0.74-1.55],0.7069429684134878
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19459,194,0.81 [0.57-1.14],0.2179214231861845
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23139,65,1.17 [0.68-2.00],0.5672514731438412
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",19417,152,1.11 [0.77-1.60],0.558254548942567
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15604,1504,1.05 [0.93-1.18],0.4071759423070861
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23191,251,0.87 [0.65-1.17],0.3731295628437943
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19859,594,0.94 [0.78-1.14],0.528618143369243
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18936,8133,1.08 [1.03-1.14],0.0025857409392345
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20836,124,1.04 [0.69-1.56],0.8578250033572657
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19607,186,1.22 [0.89-1.66],0.217514211767069
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19935,514,0.94 [0.77-1.15],0.558077700756028
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22450,3185,1.06 [0.98-1.15],0.1438966960300682
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19736,315,1.14 [0.89-1.46],0.302460756411989
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19570,149,0.77 [0.52-1.14],0.189196994622524
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19536,115,0.79 [0.51-1.24],0.3101408479498736
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22646,104,1.80 [1.25-2.60],0.0015017120560468
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16141,2041,1.05 [0.95-1.16],0.3436766362328872
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14907,807,1.41 [1.23-1.63],1.4406896413943415e-06
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23307,800,1.36 [1.18-1.57],2.1233106903545107e-05
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14178,78,1.05 [0.62-1.77],0.85139406348351
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14407,307,1.02 [0.79-1.33],0.8611239058261734
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19692,271,0.97 [0.73-1.28],0.8136568881515399
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14587,487,1.00 [0.81-1.23],0.9937968139435424
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,19347,82,1.34 [0.84-2.14],0.2174037287060752
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19957,692,1.00 [0.84-1.19],0.9998886962185636
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19585,320,1.04 [0.81-1.34],0.7539900442384473
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14556,456,1.01 [0.81-1.25],0.9465402171848264
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19494,73,1.48 [0.93-2.36],0.0999141954990768
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19482,61,0.44 [0.23-0.86],0.0162827071780242
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20796,84,2.17 [1.50-3.14],3.8610236822693086e-05
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22968,2256,1.10 [1.00-1.20],0.0550765598824797
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22297,1585,1.14 [1.02-1.27],0.0232904206849065
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23228,550,1.19 [0.99-1.44],0.0579815918161359
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17277,3177,1.05 [0.97-1.14],0.2459898303113636
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14143,43,0.90 [0.44-1.85],0.773046975331468
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19526,105,1.09 [0.71-1.67],0.7044172739354186
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14171,71,1.43 [0.88-2.32],0.1530033923062614
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14236,136,0.76 [0.50-1.16],0.2037788805168912
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20958,246,0.89 [0.66-1.20],0.4344125470867787
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21227,515,0.88 [0.72-1.09],0.2410808979021876
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23381,117,0.89 [0.58-1.38],0.6137457616576183
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21274,2009,1.06 [0.96-1.17],0.2601771856342468
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19499,78,1.06 [0.64-1.76],0.820363474618037
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14258,158,0.77 [0.52-1.15],0.201168932796328
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20064,799,1.04 [0.88-1.21],0.6615963855839087
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16314,2214,1.10 [1.00-1.21],0.0507062465819454
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22672,130,1.79 [1.29-2.48],0.0004529330649621
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23393,64,1.14 [0.67-1.95],0.6357202934279995
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19500,79,1.15 [0.71-1.86],0.5720271850901535
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20791,1370,1.10 [0.98-1.24],0.1069890710323565
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19531,110,1.44 [0.98-2.11],0.0639576108797142
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16203,2103,1.07 [0.97-1.18],0.1674480566253697
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20832,120,0.80 [0.52-1.24],0.3239221390792575
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19459,38,0.63 [0.28-1.43],0.2708401584141717
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19465,200,0.73 [0.52-1.03],0.0765478192071159
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20115,694,1.17 [1.00-1.38],0.0554219738560256
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23040,498,0.83 [0.67-1.03],0.0864926945488284
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19932,667,1.11 [0.93-1.31],0.2503142919761956
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23243,544,1.19 [0.99-1.44],0.0602601299254036
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23378,70,1.50 [0.94-2.41],0.0917623346140131
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19590,169,1.13 [0.80-1.58],0.4869065056781948
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18203,903,1.23 [1.07-1.42],0.0046312198373196
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20074,653,1.07 [0.90-1.27],0.4358367079063241
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19704,283,1.08 [0.83-1.41],0.5711215100091209
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14172,72,0.99 [0.57-1.72],0.9708249031096404
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17268,3168,1.16 [1.07-1.25],0.0001672579759974
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14949,849,1.01 [0.86-1.18],0.925992578594796
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22924,382,0.91 [0.71-1.15],0.4182688263386538
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23347,83,0.98 [0.59-1.62],0.9248848600151388
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20702,72,0.86 [0.50-1.48],0.5852465291725495
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14165,65,1.15 [0.67-1.99],0.6065899715681333
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,19375,110,0.93 [0.59-1.44],0.7337902329430628
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14658,558,1.21 [1.00-1.45],0.0467584966401032
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19762,341,0.94 [0.74-1.21],0.6494453271033446
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19557,292,1.01 [0.77-1.32],0.94514023073489
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,19534,269,0.93 [0.70-1.24],0.6198199363354464
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16436,68,0.91 [0.52-1.62],0.7601288591923077
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23383,75,1.37 [0.85-2.20],0.1962990220365733
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19985,564,0.99 [0.82-1.20],0.9136510129026904
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22634,92,0.71 [0.43-1.19],0.1985760718129413
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22098,2677,1.09 [1.00-1.19],0.0530246723242715
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19572,151,0.81 [0.55-1.19],0.278158958762584
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19989,724,1.00 [0.85-1.19],0.9592763665255628
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22020,279,0.88 [0.67-1.17],0.3753519729774515
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,19525,260,0.79 [0.59-1.07],0.1290687662067006
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21299,2034,1.02 [0.92-1.13],0.6824250446173604
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20591,1326,1.02 [0.90-1.15],0.8100961772154037
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19483,62,1.48 [0.90-2.43],0.1250868861094594
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22659,117,0.75 [0.48-1.18],0.2134230390880151
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19587,166,0.91 [0.63-1.31],0.6095522018281685
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19513,92,0.68 [0.41-1.14],0.1481225598974974
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14177,77,1.14 [0.68-1.90],0.6245259950701554
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21875,2280,1.61 [1.48-1.74],1.7886008924030532e-30
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9373,26,0.95 [0.38-2.38],0.9193384559322064
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11887,33,0.73 [0.31-1.74],0.4823312574826891
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23070,317,1.17 [0.92-1.49],0.1986303847055789
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22859,106,0.86 [0.55-1.35],0.5122052425442253
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21951,2356,1.49 [1.37-1.62],5.834715854485176e-21
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23170,134,1.89 [1.40-2.53],2.63033647538879e-05
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23090,410,1.14 [0.92-1.41],0.2271391314911748
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,19498,303,1.15 [0.89-1.48],0.2750982811345098
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Dialysis,19693,98,2.08 [1.47-2.95],3.587527686791338e-05
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10315,2174,1.04 [0.95-1.14],0.4039544822169613
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11988,134,0.92 [0.62-1.38],0.6967746534704948
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9387,40,1.22 [0.62-2.42],0.5663628420010064
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9936,589,0.65 [0.53-0.81],6.136191261872267e-05
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19285,6370,1.17 [1.11-1.24],8.329503133507802e-09
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23134,98,2.26 [1.62-3.16],1.4106515677123258e-06
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hydrocele,8261,120,1.13 [0.77-1.67],0.5268446890972547
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19665,357,1.23 [0.98-1.55],0.0707277261031671
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9998,1857,1.04 [0.94-1.16],0.4042679705413836
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12053,161,0.97 [0.67-1.39],0.8667106453927658
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8269,128,1.22 [0.85-1.76],0.2767311090226499
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19284,89,0.86 [0.52-1.41],0.5459995927288019
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10392,1045,0.93 [0.80-1.07],0.3016983917819688
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,8203,62,1.01 [0.57-1.78],0.9803132323287176
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9386,39,0.93 [0.44-1.98],0.8569017750941517
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23390,89,0.89 [0.55-1.46],0.6581366757774938
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23392,86,1.23 [0.78-1.95],0.3703371418049601
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22190,2995,1.12 [1.04-1.22],0.0049444634360886
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20151,956,1.00 [0.86-1.15],0.963026013046145
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11904,50,1.35 [0.74-2.45],0.3237689714345695
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23316,636,1.08 [0.91-1.29],0.3868528546952547
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8297,156,1.13 [0.80-1.59],0.4910241052695405
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8300,159,0.86 [0.60-1.24],0.4196026344347079
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8295,154,0.96 [0.67-1.39],0.8417793298902236
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23363,87,0.83 [0.50-1.38],0.4742788089567121
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21574,2379,1.17 [1.07-1.28],0.0005877429070231
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11975,83,0.89 [0.53-1.49],0.6546629932012706
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9416,69,1.38 [0.83-2.29],0.2095642698719958
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9489,142,0.80 [0.54-1.21],0.2949412438514019
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9398,51,1.89 [1.12-3.18],0.0165416851101114
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9450,103,1.38 [0.91-2.08],0.1287958688804383
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19729,421,1.16 [0.94-1.44],0.1726719101512925
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22885,205,0.96 [0.70-1.32],0.7904279754211619
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9472,125,1.01 [0.67-1.53],0.9584288983395606
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9372,25,0.63 [0.23-1.72],0.3653227455710404
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9560,213,0.89 [0.64-1.22],0.4633530047616382
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9442,95,1.21 [0.77-1.91],0.4062735181276152
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9558,211,1.01 [0.73-1.38],0.9723030408991564
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23083,47,0.68 [0.33-1.39],0.2878059224207334
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8298,157,1.07 [0.76-1.52],0.6813381930262855
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23109,3801,1.39 [1.30-1.49],1.9324509444619425e-22
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19404,96,1.31 [0.85-2.03],0.2187279353887403
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19778,183,2.13 [1.65-2.74],6.682196602610902e-09
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22793,40,0.98 [0.49-1.95],0.9592074281823706
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19466,271,1.05 [0.80-1.38],0.708360597367171
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23157,404,1.13 [0.92-1.40],0.2502307392830547
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9383,36,1.58 [0.82-3.05],0.1715238418056513
